CD24 and S100A4 Expression in Resectable Pancreatic Cancers With Earlier Disease Recurrence and Poor Survival

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pancreas

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/MPA.0000000000000097PMID 24622067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.

  2012cited by this paper
• Loss of E-Cadherin Expression and Outcome among Patients with Resectable Pancreatic Adenocarcinomas

  2011cited by this paper
• Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.

  2010cited by this paper
• Expression of Ezrin and Phosphorylated Ezrin (pEzrin) in Pancreatic Ductal Adenocarcinoma

  2010cited by this paper
• Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis

  2010cited by this paper
• Advanced pancreatic carcinoma: current treatment and future challenges

  2010cited by this paper
• Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.

  2010cited by this paper
• Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

  2009cited by this paper
• Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery

  2009cited by this paper
• Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma

  2009cited by this paper
• CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma

  2009cited by this paper
• RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.

  2009cited by this paper
• Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer.

  2008cited by this paper
• Adjuvant therapy for pancreatic cancer

  2008cited by this paper
• Epithelial to Mesenchymal Transition: Expression of the Regulators Snail, Slug, and Twist in Pancreatic Cancer

  2007cited by this paper
• S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer.

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Snail silencing effectively suppresses tumour growth and invasiveness

  2007cited by this paper
• Epithelial-Mesenchymal Transition (EMT) and Activated Extracellular Signal-regulated Kinase (p-Erk) in Surgically Resected Pancreatic Cancer

  2007cited by this paper
• Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

  2006cited by this paper
• Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression.

  2006cited by this paper
• Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.

  2006cited by this paper
• CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.

  2006cited by this paper
• Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.

  2005cited by this paper
• EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 14 IN HUMAN PANCREATIC CANCER CELL LINES AND CANCER TISSUES

  2005cited by this paper
• Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma

  2005cited by this paper
• CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients

  2003cited by this paper
• Prognostic significance of S100A4 expression in gallbladder cancer.

  2002cited by this paper
• Prognostic significance of calcium-binding protein S100A4 in colorectal cancer.

  2002cited by this paper
• Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

  2002cited by this paper
• The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor

  2001cited by this paper
• Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.

  2000cited by this paper
• Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.

  2000cited by this paper
• General mechanisms of metastasis

  1997cited by this paper
• Cancer statistics

  1989cited by this paper

• Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis.

  2026influential citation
• Molecular roles of microRNA-21 and exosomal miR-21 in gastrointestinal cancers: diagnostic, therapeutic, and drug resistance insights

  2025cites this paper
• Preoperative Prognostic Factors in Resectable Pancreatic Cancer: State of the Art and Prospects

  2025influential citation
• Prognostic Protein Biomarker Screening for Thyroid Carcinoma Based on Cancer Proteomics Profiles

  2024cites this paper
• Pancreatic cancer stemness: dynamic status in malignant progression

  2023cites this paper
• microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells

  2022cites this paper
• Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

  2022cites this paper
• Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

  2022cites this paper
• Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma

  2022cites this paper
• Current Pathology Model of Pancreatic Cancer

  2022cites this paper
• Engineered extracellular matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids

  2022cites this paper
• A new pancreatic adenocarcinoma‐derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms

  2021cites this paper
• S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives

  2021cites this paper
• Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?

  2020cites this paper
• The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond

  2020cites this paper
• Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma

  2020cites this paper
• S100A4 overexpression in pancreatic ductal adenocarcinoma: imaging biomarkers from whole-tumor evaluation with MRI and texture analysis

  2020cites this paper
• CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy.

  2020cites this paper
• Role of imaging biomarkers for prognostic prediction in patients with pancreatic ductal adenocarcinoma.

  2020cites this paper
• Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance

  2019cites this paper
• Prognostic value of pre-treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue

  2019cites this paper
• Understanding the biology Of CD24

  2018cites this paper
• Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling

  2018cites this paper
• The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.

  2017cites this paper
• Clinicopathological and Prognostic Value of CD24 Expression in Breast Cancer: A Meta-Analysis

  2017cites this paper
• Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis

  2017cites this paper
• Syddansk Universitet Key players in pancreatic cancer-stroma interaction

  2017cites this paper
• Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.

  2016cites this paper
• S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.

  2016cites this paper
• Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.

  2016cites this paper
• Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection.

  2016cites this paper
• Targeting cancer stem-like cells using dietary-derived agents - Where are we now?

  2016cites this paper
• Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis

  2016cites this paper
• Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.

  2015cites this paper
• N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.

  2015cites this paper
• Evaluation of S 100 A 4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer

  2015cites this paper
• Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients

  2015cites this paper
• Expression and significance of CD44 and p-AKT in pancreatic head cancer

  2015cites this paper
• CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer

  2015cites this paper
• The role of S100 proteins and their receptor RAGE in pancreatic cancer.

  2015cites this paper
• Análisis de la heterogeneidad genética del adenocarcinoma ductal de páncreas y su relación con las características de la enfermedad

  2015influential citation
• Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas

  2015cites this paper
• Faktor Prediktif Rekurensi Dini Adenokarsinoma Pankreas Setelah Bedah Reseksi Kuratif: Systematic Review

  year unknowncites this paper